Hosted on MSN
VMS TMT IPO allotment date likely today. Latest GMP, step-by-step guide to check share allotment status online
VMS TMT IPO Allotment: The initial public offering (IPO) of Thermo Mechanically Treated Bars (TMT Bars) manufacturer VMS TMT Ltd was subscribed by a massive 102 times. Investors now await VMS TMT IPO ...
Artificial intelligence (AI) has become the central force reshaping mergers and acquisitions in the technology, media, and telecom (TMT) sector. Global deal value surged 76 per cent in 2025 to $903 ...
FORT CARSON, Colo. — As George Floyd surveys the terrain of Range 127, he reflects on his career as an Infantryman and how training has evolved exponentially to meet the demands of current and future ...
Dec 15 (Reuters) - Goldman Sachs (GS.N), opens new tab is restructuring its influential technology, media, and telecom (TMT) investment banking group with an eye toward infrastructure deals and ...
With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) and Keytruda, Merck & Co.’s partner Kelun-Biotech is the latest to claim that ...
Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell lung cancer. The OptiTROP-Lung05 study is the first phase 3 trial of an ...
While Google disagrees, the company may have decided again that your data is its toy. Here's how to try to stop Gmail from training its AI on your email. There's no shortage of big tech companies that ...
SAN FRANCISCO--(BUSINESS WIRE)--Blend Labs Inc. (NYSE: BLND), a leading digital origination platform for banks, credit unions, and mortgage lenders, today announced that Nima Ghamsari, Co-Founder and ...
Gov. Josh Green is pledging to help “promptly” establish a procedure to permit construction of a controversial telescope atop Maunakea on a site previously developed for observatory use. In an Oct. 24 ...
Merck & Co. began Tuesday with back-to-back deals, revealing separate agreements to pay $150 million upfront for full control of an early-phase asset and pocket $700 million to support an expansive ...
Oct. 14, days before the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, Merck & Co. published a new clinical trial of sacituzumab tirumotecan (sac-TMT), in combination with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results